{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:16:55Z","timestamp":1794856615684,"version":"4.9.1"},"reference-count":71,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100004686","name":"Deanship of Scientific Research, King Faisal University","doi-asserted-by":"publisher","award":["186225"],"award-info":[{"award-number":["186225"]}],"id":[{"id":"10.13039\/501100004686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2020,4,7]]},"abstract":"<jats:sec>\n<jats:title>Aims and Objective:<\/jats:title>\n<jats:p>The infectious disease treatment remains a challenging concern\nowing to the increasing number of pathogenic microorganisms associated with resistance to\nmultiple drugs. A promising approach for combating microbial infection is to combine two or more\nknown bioactive heterocyclic pharmacophores in one molecular platform. Herein, the synthesis\nand biological evaluation of novel thiazole-thiazolidinone hybrids as potential antimicrobial agents\nwere dissimilated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>The preparation of the substituted 5-benzylidene-2-thiazolyimino-4-\nthiazolidinones was achieved in three steps from 2-amino-5-methylthiazoline. All the compounds\nhave been screened in PASS antibacterial activity prediction and in a panel of bacteria and fungi\nstrains. Minimum inhibitory concentration and minimum bacterial concentration were both\ndetermined by microdilution assays. Molecular modeling was conducted using Accelrys Discovery\nStudio 4.0 client. ToxPredict (OPEN TOX) and ProTox were used to estimate the toxicity of the\ntitle compounds.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>PASS prediction revealed the potentiality antibacterial property of the designed thiazolethiazolidinone\nhybrids. All tested compounds were found to kill and to inhibit the growth of a vast\nvariety of bacteria and fungi, and were more potent than the commercial drugs, streptomycin,\nampicillin, bifomazole and ketoconazole. Further, in silico study was carried out for prospective\nmolecular target identification and revealed favorable interaction with the target enzymes E. coli\nMurB and CYP51B of Aspergillus fumigatus. Toxicity prediction revealed that none of the active\ncompounds was found toxic.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Substituted 5-benzylidene-2-thiazolyimino-4-thiazolidinones, endowing remarkable\nantibacterial and antifungal properties, were identified as a novel class of antimicrobial agents and\nmay find a potential therapeutic use to eradicate infectious diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207323666200127115238","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T14:34:55Z","timestamp":1580135695000},"page":"126-140","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Novel Thiazole-Based Thiazolidinones as Potent Anti-infective Agents: <i>In silico<\/i> PASS and Toxicity Prediction, Synthesis, Biological Evaluation and Molecular Modelling"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9064-1706","authenticated-orcid":true,"given":"Christophe","family":"Tratrat","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5245021","volume":"2017","author":"Nii-Trebi N.I.","year":"2017","unstructured":"Nii-Trebi N.I.; Emerging and neglected infectious diseases: insights, advances, and challenges. BioMed Res Int 2017,2017","journal-title":"BioMed Res Int"},{"key":"ref=2","first-page":"459","volume":"62","author":"Mukherjee S.","year":"2017","unstructured":"Mukherjee S.; Emerging infectious diseases: epidemiological perspective. Indian J Dermatol 2017,62(5),459-467","journal-title":"Indian J Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"j831","DOI":"10.1136\/bmj.j831","volume":"356","author":"Young V.B.","year":"2017","unstructured":"Young V.B.; The role of the microbiome in human health and disease: an introduction for clinicians. BMJ 2017,356,j831","journal-title":"BMJ"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-016-0294-z","volume":"8","author":"Langdon A.","year":"2016","unstructured":"Langdon A.; Crook N.; Dantas G.; The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 2016,8(1),39-39","journal-title":"Genome Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1164\/rccm.201410-1894OE","volume":"191","author":"Spellberg B.","year":"2015","unstructured":"Spellberg B.; Bartlett J.; Wunderink R.; Gilbert D.N.; Novel approaches are needed to develop tomorrow\u2019s antibacterial therapies. Am J Respir Crit Care Med 2015,191(2),135-140","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/14787210.2017.1387535","volume":"15","author":"Cataldo M.A.","year":"2017","unstructured":"Cataldo M.A.; Granata G.; Petrosillo N.; Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship. Expert Rev Anti Infect Ther 2017,15(11),1027-1040","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1111\/bph.13706","volume":"174","author":"Hughes G.","year":"2017","unstructured":"Hughes G.; Webber M.A.; Novel approaches to the treatment of bacterial biofilm infections. Br J Pharmacol 2017,174(14),2237-2246","journal-title":"Br J Pharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2174\/1389557516666160609075620","volume":"16","author":"Desai N.","year":"2016","unstructured":"Desai N.; Trivedi A.; Pandit U.; Dodiya A.; Rao V.K.; Desai P.; Hybrid bioactive heterocycles as potential antimicrobial agents: a review. Mini Rev Med Chem 2016,16(18),1500-1526","journal-title":"Mini Rev Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejmech.2015.08.005","volume":"102","author":"Dawood K.M.","year":"2015","unstructured":"Dawood K.M.; Eldebss T.M.; El-Zahabi H.S.; Yousef M.H.; Synthesis and antiviral activity of some new bis-1,3-thiazole derivatives. Eur J Med Chem 2015,102,266-276","journal-title":"Eur J Med Chem"},{"key":"ref=10","first-page":"352","author":"Li Z.","year":"2009","unstructured":"Li Z.; Chen Y.; Zhou Z.; Deng L.; Xu Y.; Hu L.; Liu B.; Zhang L.; Discovery of first-in-class thiazole-based dual FFA1\/PPAR\u03b4 agonists as potential anti-diabetic agents. Eur. J. Med. Chem., 2019, 164. Diabetes 58 2009,352-365","journal-title":"Diabetes 58"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/molecules24030539","volume":"24","author":"Abu-Melha S.","year":"2019","unstructured":"Abu-Melha S.; Edrees M.M.; Salem H.H.; Kheder N.A.; Gomha S.M.; Abdelaziz M.R.; Synthesis and biological evaluation of some novel thiazole-based heterocycles as potential anticancer and antimicrobial agents. Molecules 2019,24(3),539","journal-title":"Molecules"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/molecules24091741","volume":"24","author":"Althagafi I.","year":"2019","unstructured":"Althagafi I.; El-Metwaly N.; Farghaly T.A.; New series of thiazole derivatives: synthesis, structural elucidation, antimicrobial activity, molecular modeling and MOE docking. Molecules 2019,24(9),1741","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/1568026619666190129121933","volume":"19","author":"Tratrat C.","year":"2019","unstructured":"Tratrat C.; Haroun M.; Xenikakis I.; Liaras K.; Tsolaki E.; Eleftheriou P.; Petrou A.; Aldhubiab B.; Attimarad M.; Venugopala K.N.; Harsha S.; Elsewedy H.S.; Geronikaki A.; Sokovi\u0107 M.; Design, synthesis, evaluation of antimicrobial activity and docking studies of new thiazole-based chalcones. Curr Top Med Chem 2019,19(5),356-375","journal-title":"Curr Top Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.steroids.2015.03.001","volume":"98","author":"Mohareb R.M.","year":"2015","unstructured":"Mohareb R.M.; Zaki M.Y.; Abbas N.S.; Synthesis, anti-inflammatory and anti-ulcer evaluations of thiazole, thiophene, pyridine and pyran derivatives derived from androstenedione. Steroids 2015,98,80-91","journal-title":"Steroids"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2019.127024","volume":"1199","author":"Khamees H.A.","year":"2020","unstructured":"Khamees H.A.; Mohammed Y.H.E.S.; A.; Al-Ostoot, F. H.; Y, S.; Alghamdi, S.; Khanum, S. A.; Madegowda, M. Effect of o-difluoro and p-methyl substituents on the structure, optical properties and anti-inflammatory activity of phenoxy thiazole acetamide derivatives: theoretical and experimental studies. J Mol Struct 2020,1199","journal-title":"J Mol Struct"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/molecules23030685","volume":"23","author":"Liaras K.","year":"2018","unstructured":"Liaras K.; Fesatidou M.; Geronikaki A.; Thiazoles and thiazolidinones as COX\/LOX inhibitors. Molecules 2018,23(3),685","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/14756366.2018.1426573","volume":"33","author":"Ugwu D.I.","year":"2018","unstructured":"Ugwu D.I.; Okoro U.C.; Ukoha P.O.; Gupta A.; Okafor S.N.; Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies. J Enzyme Inhib Med Chem 2018,33(1),405-415","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ejmech.2013.04.005","volume":"65","author":"Helal M.H.","year":"2013","unstructured":"Helal M.H.; Salem M.A.; El-Gaby M.S.; Aljahdali M.; Synthesis and biological evaluation of some novel thiazole compounds as potential anti-inflammatory agents. Eur J Med Chem 2013,65,517-526","journal-title":"Eur J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4274\/tjps.25743","volume":"14","author":"Ulusoy G\u00fczeldemirci N.","year":"2017","unstructured":"Ulusoy G\u00fczeldemirci N.; Karaman Mayack B.; K\u00dc\u00c7\u00dcKbasmaci, \u00d6. Antibacterial, antitubercular and antiviral activity evaluations of some arylidenehydrazide derivatives bearing imidazo[2,1-b] thiazole moiety. Turkish J Pharma Sci 2017,14,157-163","journal-title":"Turkish J Pharma Sci"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155209","volume":"11","author":"Kesicki E.A.","year":"2016","unstructured":"Kesicki E.A.; Bailey M.A.; Ovechkina Y.; Early J.V.; Alling T.; Bowman J.; Zuniga E.S.; Dalai S.; Kumar N.; Masquelin T.; Hipskind P.A.; Odingo J.O.; Parish T.; Synthesis and evaluation of the 2-aminothiazoles as anti-tubercular agents. PLoS One 2016,11(5)","journal-title":"PLoS One"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.1016\/j.bmc.2004.09.016","volume":"12","author":"Geronikaki A.","year":"2004","unstructured":"Geronikaki A.; Babaev E.; Dearden J.; Dehaen W.; Filimonov D.; Galaeva I.; Krajneva V.; Lagunin A.; Macaev F.; Molodavkin G.; Poroikov V.; Pogrebnoi S.; Saloutin V.; Stepanchikova A.; Stingaci E.; Tkach N.; Vlad L.; Voronina T.; Design, synthesis, computational and biological evaluation of new anxiolytics. Bioorg Med Chem 2004,12(24),6559-6568","journal-title":"Bioorg Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/1573406415666190515093657","volume":"15","author":"Haroun M.","year":"2019","unstructured":"Haroun M.; Novel hybrids of pyrazolidinedione and benzothiazole as TZD analogues. rationale design, synthesis and in vivo anti-diabetic evaluation. Med Chem 2019,15(6),624-633","journal-title":"Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13065-019-0632-5","volume":"13","author":"Sayed A.R.","year":"2019","unstructured":"Sayed A.R.; Gomha S.M.; Abdelrazek F.M.; Farghaly M.S.; Hassan S.A.; Metz P.; Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents. BMC Chem 2019,13(1),116","journal-title":"BMC Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2174\/1389557518666180424113819","volume":"18","author":"Gomha S.M.","year":"2018","unstructured":"Gomha S.M.; Abdelhamid A.O.; Kandil O.M.; Kandeel S.M.; Abdelrehem N.A.; Synthesis and molecular docking of some novel thiazoles and thiadiazoles incorporating pyranochromene moiety as potent anticancer agents. Mini Rev Med Chem 2018,18(19),1670-1682","journal-title":"Mini Rev Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.ejmech.2008.05.029","volume":"44","author":"Kouatly O.","year":"2009","unstructured":"Kouatly O.; Geronikaki A.; Kamoutsis C.; Hadjipavlou-Litina D.; Eleftheriou P.; Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents. Eur J Med Chem 2009,44(3),1198-1204","journal-title":"Eur J Med Chem"},{"key":"ref=26","first-page":"180","volume":"2","author":"Hassan F.","year":"2012","unstructured":"Hassan F.; Synthesis, characterization, anti-inflammatory, and antioxidant activities of some new thiazole derivatives. Int J Appl Sci Technol 2012,2(7),180-187","journal-title":"Int J Appl Sci Technol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1016\/j.ejmech.2009.03.038","volume":"44","author":"el-Sabbagh O.I.","year":"2009","unstructured":"el-Sabbagh O.I.; Baraka M.M.; Ibrahim S.M.; Pannecouque C.; Andrei G.; Snoeck R.; Balzarini J.; Rashad A.A.; Synthesis and antiviral activity of new pyrazole and thiazole derivatives. Eur J Med Chem 2009,44(9),3746-3753","journal-title":"Eur J Med Chem"},{"key":"ref=28","first-page":"1072","volume":"2","author":"Jain A.","year":"2011","unstructured":"Jain A.; Singla R.K.; Shrivastava B.; Thiazole: a remarkable antimicrobial and antioxidant agents. Pharmacologyonline 2011,2,1072-1084","journal-title":"Pharmacologyonline"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1016\/j.bmc.2007.04.003","volume":"15","author":"Shiradkar M.R.","year":"2007","unstructured":"Shiradkar M.R.; Murahari K.K.; Gangadasu H.R.; Suresh T.; Kalyan C.A.; Panchal D.; Kaur R.; Burange P.; Ghogare J.; Mokale V.; Raut M.; Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents. Bioorg Med Chem 2007,15(12),3997-4008","journal-title":"Bioorg Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ejmech.2018.12.069","volume":"164","author":"Li Z.","year":"2019","unstructured":"Li Z.; Chen Y.; Zhou Z.; Deng L.; Xu Y.; Hu L.; Liu B.; Zhang L.; Discovery of first-in-class thiazole-based dual FFA1\/PPAR\u03b4 agonists as potential anti-diabetic agents. Eur J Med Chem 2019,164,352-365","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1570163814666170915134018","volume":"15","author":"Khatik G.L.","year":"2018","unstructured":"Khatik G.L.; Datusalia A.K.; Ahsan W.; Kaur P.; Vyas M.; Mittal A.; Nayak S.K.; A retrospect study on thiazole derivatives as the potential antidiabetic agents in drug discovery and developments. Curr Drug Discov Technol 2018,15(3),163-177","journal-title":"Curr Drug Discov Technol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ejmech.2008.04.006","volume":"44","author":"Geronikaki A.","year":"2009","unstructured":"Geronikaki A.; Vicini P.; Dabarakis N.; Lagunin A.; Poroikov V.; Dearden J.; Modarresi H.; Hewitt M.; Theophilidis G.; Evaluation of the local anaesthetic activity of 3-aminobenzo[d]isothiazole derivatives using the rat sciatic nerve model. Eur J Med Chem 2009,44(2),473-481","journal-title":"Eur J Med Chem"},{"key":"ref=33","first-page":"763","volume":"71","author":"Bhat M.A.","year":"2014","unstructured":"Bhat M.A.; Synthesis and anti-mycobacterial activity of new 4-thiazolidinone and 1,3,4-oxadiazole derivatives of isoniazid. Acta Pol Pharm 2014,71(5),763-770","journal-title":"Acta Pol Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejmech.2013.03.030","volume":"64","author":"Kunzler A.","year":"2013","unstructured":"Kunzler A.; Neuenfeldt P.D.; das Neves, A.M.; Pereira, C.M.; Marques, G.H.; Nascente, P.S.; Fernandes, M.H.; H\u00fcbner, S.O.; Cunico, W. Synthesis, antifungal and cytotoxic activities of 2-aryl-3-((piperidin-1-yl)ethyl)thiazolidinones. Eur J Med Chem 2013,64,74-80","journal-title":"Eur J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/15734064113099990030","volume":"10","author":"Marques G.H.","year":"2014","unstructured":"Marques G.H.; Kunzler A.; Bare\u00f1o V.D.; Drawanz B.B.; Mastelloto H.G.; Leite F.R.; Nascimento G.G.; Nascente P.S.; Siqueira G.M.; Cunico W.; Antifungal activity of 3-(heteroaryl-2-ylmethyl)thiazolidinone derivatives. Med Chem 2014,10(4),355-360","journal-title":"Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s11030-016-9691-x","volume":"20","author":"Chen N.","year":"2016","unstructured":"Chen N.; Duan W.; Lin G.; Liu L.; Zhang R.; Li D.; Synthesis and antifungal activity of dehydroabietic acid-based 1,3,4-thiadiazole-thiazolidinone compounds. Mol Divers 2016,20(4),897-905","journal-title":"Mol Divers"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cbi.2016.12.008","volume":"262","author":"Szychowski K.A.","year":"2017","unstructured":"Szychowski K.A.; Leja M.L.; Kaminskyy D.V.; Binduga U.E.; Pinyazhko O.R.; Lesyk R.B.; Gmi\u0144ski J.; Study of novel anticancer 4-thiazolidinone derivatives. Chem Biol Interact 2017,262,46-56","journal-title":"Chem Biol Interact"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1039\/C8NJ03671C","volume":"43","author":"Adiyodi S.","year":"2019","unstructured":"Adiyodi S.; Damodara J.; Kulal A.; Rajith S.; Kumar Shankar M.; Chandrashekara R.; Kumar V.; Punchapady-Devasya R.; Naral D.; Synthesis, structural, biological and in silico studies of some new 5-arylidene-4-thiazolidinone derivatives as possible anticancer, antimicrobial and antitubercular agents. New J Chem 2019,43,1597-1610","journal-title":"New J Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1016\/j.tetlet.2017.10.070","volume":"58","author":"Angapelly S.","year":"2017","unstructured":"Angapelly S.; Sri Ramya P.V.; SunithaRani, R.; Kumar, C.G.; Kamal, A.; Arifuddin, M. Ultrasound assisted, VOSO catalyzed synthesis of 4-thiazolidinones: antimicrobial evaluation of indazole-4-thiazolidinone derivatives. Tetrahedron Lett 2017,58(49),4632-4637","journal-title":"Tetrahedron Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1568026619666190122152957","volume":"19","author":"Merlani M.","year":"2019","unstructured":"Merlani M.; Barbakadze V.; Amiranashvili L.; Gogilashvili L.; Poroikov V.; Petrou A.; Geronikaki A.; Ciric A.; Glamoclija J.; Sokovic M.; New caffeic acid derivatives as antimicrobial agents: design, synthesis, evaluation and docking. Curr Top Med Chem 2019,19(4),292-304","journal-title":"Curr Top Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1016\/j.bmc.2018.08.004","volume":"26","author":"Fesatidou M.","year":"2018","unstructured":"Fesatidou M.; Zagaliotis P.; Camoutsis C.; Petrou A.; Eleftheriou P.; Tratrat C.; Haroun M.; Geronikaki A.; Ciric A.; Sokovic M.; 5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation. Bioorg Med Chem 2018,26(16),4664-4676","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.arabjc.2010.11.015","volume":"7","author":"Samadhiya P.","year":"2014","unstructured":"Samadhiya P.; Sharma R.; Srivastava S.K.; Srivastava S.D.; Synthesis and biological evaluation of 4-thiazolidinone derivatives as antitubercular and antimicrobial agents. Arab J Chem 2014,7(5),657-665","journal-title":"Arab J Chem"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8086762","volume":"2016","author":"Gupta A.","year":"2016","unstructured":"Gupta A.; Singh R.; Sonar P.K.; Saraf S.K.; Novel 4-thiazolidinone derivatives as anti-infective agents: synthesis, characterization, and antimicrobial evaluation. Biochem Res Int 2016,2016","journal-title":"Biochem Res Int"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1039\/C4MD00399C","volume":"6","author":"Pitta E.","year":"2015","unstructured":"Pitta E.; Tsolaki E.; Geronikaki A.; Petrovic J.; Glamoclija J.; Sokovi\u0107 M.; Crespan E.; Maga G.; Bhunia s.; Saxena A.; Saxena, A. 4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies. MedChemComm 2015,6,319-326","journal-title":"MedChemComm"},{"key":"ref=45","first-page":"51","volume":"66","author":"Imran M.","year":"2009","unstructured":"Imran M.; Yar M.S.; Khan S.A.; Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-[4-(1-naphthyl)-1,3-thiazol-2-yl] amino-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives. Acta Pol Pharm 2009,66(1),51-56","journal-title":"Acta Pol Pharm"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1021\/jm701496h","volume":"51","author":"Geronikaki A.A.","year":"2008","unstructured":"Geronikaki A.A.; Lagunin A.A.; Hadjipavlou-Litina D.I.; Eleftheriou P.T.; Filimonov D.A.; Poroikov V.V.; Alam I.; Saxena A.K.; Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase\/lipoxygenase inhibition. J Med Chem 2008,51(6),1601-1609","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bmc.2012.10.046","volume":"21","author":"Apostolidis I.","year":"2013","unstructured":"Apostolidis I.; Liaras K.; Geronikaki A.; Hadjipavlou-Litina D.; Gavalas A.; Sokovi\u0107 M.; Glamo\u010dlija J.; \u0106iri\u0107 A.; Synthesis and biological evaluation of some 5-arylidene-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-ones as dual anti-inflammatory\/ antimicrobial agents. Bioorg Med Chem 2013,21(2),532-539","journal-title":"Bioorg Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0014-2999(02)01888-5","volume":"448","author":"Ottan\u00e1 R.","year":"2002","unstructured":"Ottan\u00e1 R.; Mazzon E.; Dugo L.; Monforte F.; Maccari R.; Sautebin L.; De Luca G.; Vigorita M.G.; Alcaro S.; Ortuso F.; Caputi A.P.; Cuzzocrea S.; Modeling and biological evaluation of 3,3\u2032-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor. Eur J Pharmacol 2002,448(1),71-80","journal-title":"Eur J Pharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2014.05.003","volume":"81","author":"Maccari R.","year":"2014","unstructured":"Maccari R.; Vitale R.M.; Ottan\u00e0 R.; Rocchiccioli M.; Marrazzo A.; Cardile V.; Graziano A.C.; Amodeo P.; Mura U.; Del Corso A.; Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents. Eur J Med Chem 2014,81,1-14","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ardp.201500020","volume":"348","author":"Nikalje A.P.","year":"2015","unstructured":"Nikalje A.P.; Ansari A.; Bari S.; Ugale V.; Synthesis, biological activity, and docking study of novel isatin coupled thiazolidin-4-one derivatives as anticonvulsants. Arch Pharm (Weinheim) 2015,348(6),433-445","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jscs.2012.09.001","volume":"20","author":"Dwivedi J.","year":"2016","unstructured":"Dwivedi J.; Devi K.; Asmat Y.; Jain S.; Sharma S.; Synthesis, characterization, antibacterial and antiepileptic studies of some novel thiazolidinone derivatives. J Saudi Chem Soc 2016,20,S16-S20","journal-title":"J Saudi Chem Soc"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s11030-015-9578-2","volume":"19","author":"Iyer P.","year":"2015","unstructured":"Iyer P.; Bolla J.; Kumar V.; Gill M.S.; Sobhia M.E.; \n                        In silico identification of targets for a novel scaffold, 2-thiazolylimino-5-benzylidin-thiazolidin-4-one. Mol Divers 2015,19(4),855-870","journal-title":"Mol Divers"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/2211362611208020075","volume":"10","author":"Desai N.","year":"2012","unstructured":"Desai N.; Rajpara K.; Joshi V.; Vaghani H.; Satodiya H.M.; Synthesis and characterization of some new thiazole based thiazolidinone derivatives as potent antimicrobial and antimycobacterial agents. Antiinfect Agents 2012,10,75-86","journal-title":"Antiinfect Agents"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1016\/j.bmc.2006.01.043","volume":"14","author":"Vicini P.","year":"2006","unstructured":"Vicini P.; Geronikaki A.; Anastasia K.; Incerti M.; Zani F.; Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones. Bioorg Med Chem 2006,14(11),3859-3864","journal-title":"Bioorg Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1386207319666151203002348","volume":"19","author":"Haroun M.","year":"2016","unstructured":"Haroun M.; Tratrat C.; Tsolaki E.; Geronikaki A.; Thiazole-based thiazolidinones as potent antimicrobial agents. design, synthesis and biological evaluation. Comb Chem High Throughput Screen 2016,19(1),51-57","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1568026618666180206101814","volume":"18","author":"Haroun M.","year":"2018","unstructured":"Haroun M.; Tratrat C.; Kositsi K.; Tsolaki E.; Petrou A.; Aldhubiab B.; Attimarad M.; Harsha S.; Geronikaki A.; Venugopala K.N.; Elsewedy H.S.; Sokovic M.; Glamoclija J.; Ciric A.; New benzothiazole-based thiazolidinones as potent antimicrobial agents. design, synthesis and biological evaluation. Curr Top Med Chem 2018,18(1),75-87","journal-title":"Curr Top Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","volume":"16","author":"Lagunin A.","year":"2000","unstructured":"Lagunin A.; Stepanchikova A.; Filimonov D.; Poroikov V.; PASS: prediction of activity spectra for biologically active substances. Bioinformatics 2000,16(8),747-748","journal-title":"Bioinformatics"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/molecules21050568","volume":"21","author":"Ahmed S.","year":"2016","unstructured":"Ahmed S.; Zayed M.F.; El-Messery S.M.; Al-Agamy M.H.; Abdel-Rahman H.M.; Design, synthesis, antimicrobial evaluation and molecular modeling study of 1,2,4-triazole-based 4-thiazolidinones. Molecules 2016,21(5),568","journal-title":"Molecules"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.arabjc.2010.10.032","volume":"7","author":"Deep A.","year":"2014","unstructured":"Deep A.; Jain S.; Sharma P.C.; Mittal S.K.; Phogat P.; Malhotra M.; Synthesis, characterization and antimicrobial evaluation of 2,5-disubstituted-4-thiazolidinone derivatives. Arab J Chem 2014,7(3),287-291","journal-title":"Arab J Chem"},{"key":"ref=60","first-page":"1329","volume":"8","author":"Fuloria N.","year":"2014","unstructured":"Fuloria N.; Fuloria S.; Gupta R.; Synthesis and antimicrobial profile of newer schiff bases and thiazolidinone derivatives. world academy of science, engineering and technology, international journal of chemical, molecular, nuclear. Materials and Metallurgical Engineering 2014,8(12),1329-1332","journal-title":"Materials and Metallurgical Engineering"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1515\/abm-2018-0015","volume":"11","author":"Pham D.T.","year":"2018","unstructured":"Pham D.T.; Vo T.; Truong P.; Ho P.; Nguyen M.; Antimicrobial activity of some novel 2-(2-iodophenylimino)-5-arylidenethiazolidin-4-one derivatives. Asian Biomed 2018,11,405-412","journal-title":"Asian Biomed"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/1062936X.2019.1665099","volume":"30","author":"Rudik A.V.","year":"2019","unstructured":"Rudik A.V.; Dmitriev A.V.; Lagunin A.A.; Filimonov D.A.; Poroikov V.V.; PASS-based prediction of metabolites detection in biological systems. SAR QSAR Environ Res 2019,30(10),751-758","journal-title":"SAR QSAR Environ Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1021\/jm031086k","volume":"47","author":"Geronikaki A.A.","year":"2004","unstructured":"Geronikaki A.A.; Dearden J.C.; Filimonov D.; Galaeva I.; Garibova T.L.; Gloriozova T.; Krajneva V.; Lagunin A.; Macaev F.Z.; Molodavkin G.; Poroikov V.V.; Pogrebnoi S.I.; Shepeli F.; Voronina T.A.; Tsitlakidou M.; Vlad L.; Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation. J Med Chem 2004,47(11),2870-2876","journal-title":"J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/1062936X.2017.1323796","volume":"28","author":"Stasevych M.","year":"2017","unstructured":"Stasevych M.; Zvarych V.; Lunin V.; Deniz N.G.; Gokmen Z.; Akgun O.; Ulukaya E.; Poroikov V.; Gloriozova T.; Novikov V.; Computer-aided prediction and cytotoxicity evaluation of dithiocarbamates of 9,10-anthracenedione as new anticancer agents. SAR QSAR Environ Res 2017,28(5),355-366","journal-title":"SAR QSAR Environ Res"},{"key":"ref=65","doi-asserted-by":"crossref","unstructured":"Pogodin, P.V.; Lagunin, A.A.; Rudik, A.V.; Filimonov, D.A.; Druzhilovskiy, D.S.; Nicklaus, M.C.; Poroikov, V.V. How to achieve better results using pass-based virtual screening: case study for kinase inhibitors. Front Chem., 2018, 6(Article 133), 1-14.","DOI":"10.3389\/fchem.2018.00133"},{"key":"ref=66","unstructured":"Opentox.\n                     https:\/\/opentox.net\/library\/toxicity-prediction(Accessed on May 5th 2018)"},{"key":"ref=67","unstructured":"ToxPredict. \n                     https:\/\/apps.ideaconsult.net\/ToxPredict(Accessed on May 11th, 2018)"},{"key":"ref=68","unstructured":"Protox. \n                     ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/tox.charite.de\/protox_II\/\">http:\/\/tox.charite.de\/protox_II\/(Accessed on May 11th 2018)"},{"key":"ref=69","unstructured":"ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.unece.org\/trans\/danger\/publi\/ghs\/ghs_welcome_e.html\">http:\/\/www.unece.org\/trans\/danger\/publi\/ghs\/ghs_welcome_e.html (Accessed on May 11th 2018)"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejmech.2019.03.020","volume":"170","author":"Emami S.","year":"2019","unstructured":"Emami S.; Ghobadi E.; Saednia S.; Hashemi S.M.; Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies. Eur J Med Chem 2019,170,173-194","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1021\/jm500739f","volume":"57","author":"Friggeri L.","year":"2014","unstructured":"Friggeri L.; Hargrove T.Y.; Rachakonda G.; Williams A.D.; Wawrzak Z.; Di Santo R.; De Vita D.; Waterman M.R.; Tortorella S.; Villalta F.; Lepesheva G.I.; Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14\u03b1-demethylase: two regions of the enzyme molecule potentiate its inhibition. J Med Chem 2014,57(15),6704-6717","journal-title":"J Med Chem"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/178632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T12:51:19Z","timestamp":1587732679000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/178632\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207323666200127115238","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}